MELODIE GAVIN: Open Payments
NPI 1053725085 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,473 in 151 payments from 15 companies in 2025. Trend: 2023 $1,346 · 2024 $1,992 · 2025 $2,473
Food & beverage: $2,354Education: $119
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $493 |
| Lundbeck LLC | 30 | $397 |
| Otsuka America Pharmaceutical, Inc. | 16 | $359 |
| Axsome Therapeutics, Inc. | 9 | $256 |
| Vanda Pharmaceuticals Inc. | 16 | $167 |
| E.R. Squibb & Sons, L.L.C. | 11 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $144 |
| Alkermes, Inc. | 6 | $121 |
| Neurocrine BioSciences, Inc. | 4 | $89 |
| Indivior Inc. | 4 | $74 |
Products named: REXULTI, VRAYLAR, Auvelity, ABILIFY ASIMTUFII, CAPLYTA, FANAPT, ARISTADA, INGREZZA.
Industry payments across IN — which companies pay providers there.
